Clinical Trials in Cleveland

Showing 4501-4520 of 15,050 trials

WITHDRAWNEARLY Phase 1< 1 mile

Study Evaluating the Safety of Myeliviz Myelin-Targeting PET Agent

NCT04333290

This study evaluates the safety of \[11C\]MeDAS, a PET radiotracer.

Healthy

Robert FoxStarted Jul 2024

Cleveland, Ohio, United States

TERMINATEDPhase 1/2< 1 mile

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

NCT04718675

Part 1: Dose Escalation. The primary objective of Part 1 of this study is to evaluate the safety and tolerability of KB-0742 in participants with relapsed or refractory (R/R) solid tumors or non-Hodgkin lymphoma (NHL). Part 2: Cohort Expansion. The primary objective of Part 2 of this study is to further evaluate the safety and tolerability of KB-0742 in defined participant cohorts including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC).

Relapsed Solid TumorsRefractory Solid TumorsNon-Hodgkin Lymphoma+2 more

Kronos Bio135 participantsStarted Feb 2021

Birmingham, Alabama, United States • Duarte, California, United States • Fountain Valley, California, United States +21 more locations

Study Evaluating the Safety of Myeliviz Myelin-Targeting PET Agent

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Find Trials by Condition in Cleveland

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Alcoholic Hepatitis Network Observational Study

Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

Evaluation of the Phased Radio Frequency Ablation System

Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF

Using Calcium Hydroxylapatite To Treat Gum Recession and Tooth Hypersensitivity

Myeloma-Developing Regimens Using Genomics (MyDRUG)

INFINITY™Total Ankle Replacement Follow-up

Neuroblastoma Precision Trial

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

A Safety, Tolerability, and Efficacy Study of BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease

TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)

Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome

COVID-19 Vaccine Response in Sickle Cell Disease

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis